Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

High-dose therapy and autologous stem cell transplantation (HDT-ASCT) can offer potential long-term remission or cure in patients with non-Hodgkin lymphoma (NHL). Limited experience is available on the safety and efficacy of HDT-ASCT in elderly patients. This is a single-center, retrospective study...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Dahi, Parastoo B., Tamari, Roni, Devlin, Sean M., Maloy, Molly, Bhatt, Valkal, Scordo, Michael, Goldberg, Jenna, Zelenetz, Andrew D., Hamlin, Paul A., Matasar, Matthew J., Maragulia, Jocelyn, Giralt, Sergio A., Perales, Miguel-Angel, Moskowitz, Craig H., Sauter, Craig S.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480286/
https://ncbi.nlm.nih.gov/pubmed/25175794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.08.019
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares